阿拉丁 |
C124894-5mg |
5mg |
期货,请咨询 |
1333377-65-3 |
CHR-6494,haspin 抑制剂 CHR-6494 |
≥98% |
219.90
219.90
|
|
阿拉丁 |
C124894-10mg |
10mg |
期货,请咨询 |
1333377-65-3 |
CHR-6494,haspin 抑制剂 CHR-6494 |
≥98% |
417.90
417.90
|
|
阿拉丁 |
C124894-50mg |
50mg |
期货,请咨询 |
1333377-65-3 |
CHR-6494,haspin 抑制剂 CHR-6494 |
≥98% |
1,886.90
1,886.90
|
|
阿拉丁 |
C124894-100mg |
100mg |
期货,请咨询 |
1333377-65-3 |
CHR-6494,haspin 抑制剂 CHR-6494 |
≥98% |
3,469.90
3,469.90
|
|
阿拉丁 |
C124894-25mg |
25mg |
期货,请咨询 |
1333377-65-3 |
CHR-6494,haspin 抑制剂 CHR-6494 |
≥98% |
992.90
992.90
|
|
麦克林 |
C883192-5mg |
5mg |
|
1333377-65-3 |
CHR-6494 CHR-6494 |
|
518.00
518.00
|
|
麦克林 |
C883192-10mg |
10mg |
|
1333377-65-3 |
CHR-6494 CHR-6494 |
|
976.00
976.00
|
|
罗恩 |
R022200-10mg |
10mg |
5~7个工作日 |
1333377-65-3 |
3-(1H-吲唑-5-基)-n-丙基-咪唑并[1,2-b... CHR-6494 |
98% |
1,108.00
1,108.00
|
|
罗恩 |
R022200-5mg |
5mg |
5~7个工作日 |
1333377-65-3 |
3-(1H-吲唑-5-基)-n-丙基-咪唑并[1,2-b... CHR-6494 |
98% |
588.00
588.00
|
|
GLPBIO |
GC17254-5 |
5mg |
|
1333377-65-3 |
CHR-6494 |
|
504.00
504.00
|
|
GLPBIO |
GC17254-10 |
10mg |
|
1333377-65-3 |
CHR-6494 |
|
935.00
935.00
|
|
GLPBIO |
GC17254-50 |
50mg |
|
1333377-65-3 |
CHR-6494 |
|
2,888.00
2,888.00
|
|
GLPBIO |
GC17254-100 |
100mg |
|
1333377-65-3 |
CHR-6494 |
|
4,589.00
4,589.00
|
|
毕得 |
BD304632-10mg |
10mg |
现货 |
1333377-65-3 |
3-(1H-吲唑-5-基)-N-丙基咪唑并[1,2-b]... 3-(1H-Indazol-5-yl)-N-propyl... |
99% |
1,058.00
1,058.00
|
|
毕得 |
BD304632-50mg |
50mg |
现货 |
1333377-65-3 |
3-(1H-吲唑-5-基)-N-丙基咪唑并[1,2-b]... 3-(1H-Indazol-5-yl)-N-propyl... |
99% |
3,058.00
3,058.00
|
|
毕得 |
BD304632-25mg |
25mg |
现货 |
1333377-65-3 |
3-(1H-吲唑-5-基)-N-丙基咪唑并[1,2-b]... 3-(1H-Indazol-5-yl)-N-propyl... |
99% |
1,799.00
1,799.00
|
|
MedMol |
S82876-5mg |
5mg |
|
1333377-65-3 |
CHR-6494 CHR-6494 |
|
440.00
440.00
|
|
MedMol |
S82876-10mg |
10mg |
|
1333377-65-3 |
CHR-6494 CHR-6494 |
|
830.00
830.00
|
|
MedMol |
S82876-50mg |
50mg |
|
1333377-65-3 |
CHR-6494 CHR-6494 |
|
3,100.00
3,100.00
|
|
MedMol |
S82876-100mg |
100mg |
|
1333377-65-3 |
CHR-6494 CHR-6494 |
|
5,400.00
5,400.00
|
|